2023 annual financial data
TransCode Therapeutics 2023 Operating margin
TransCode Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -19,418,516 USD and net income was -18,546,095 USD.
Operating cash flow was -18,074,535 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -19,418,516 USD
- Net income
- -18,546,095 USD
- Operating cash flow
- -18,074,535 USD